Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Applications for Food and Drug Administration Approval To Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs; Correction, 42713 [2011-18143]

Download as PDF Federal Register / Vol. 76, No. 138 / Tuesday, July 19, 2011 / Notices meeting and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Jennifer Brooks at least seven days in advance of the meeting. Information about the Committee and this meeting can be found at the Committee Web site, https://www.acf.hhs.gov/programs/opre/ hs/advisory_com/. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: June 29, 2011. George H. Sheldon, Acting Assistant Secretary for Children and Families. [FR Doc. 2011–18098 Filed 7–18–11; 8:45 am] BILLING CODE 4184–22–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Notice of Meeting; Administration for Native Americans Administration for Children and Families, Department of Health and Human Services. ACTION: Notice of Tribal Consultation. sroberts on DSK5SPTVN1PROD with NOTICES AGENCY: SUMMARY: The Department of Health and Human Services (HHS), Administration for Children and Families (ACF) will host a tribal consultation to solicit input on the agency’s programs. DATES: August 18, 2011. ADDRESSES: Room 800, 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Lillian A. Sparks, Commissioner, Administration for Native Americans, at 202–401–5590, by e-mail at Lillian.sparks@acf.hhs.gov or by mail at 370 L’Enfant Promenade, SW., 2 West, Washington, DC 20447. SUPPLEMENTARY INFORMATION: On September 29, 2010, ACF held its first Tribal Consultation Session in 5 years. The purpose of that session was to receive input to ACF’s draft Tribal Consultation Policy and ACF has been working hard to finalize that policy. ACF Principals will once again be available to speak with tribal leaders to discuss issues important to the tribes. This year’s session will focus on ACF tribal program priorities and will include a listening session on tribal selfgovernance. Testimonies may be submitted no later than August 5, 2011, to: Lillian Sparks, Commissioner, VerDate Mar<15>2010 17:20 Jul 18, 2011 Jkt 223001 42713 Administration for Native Americans, 370 L’Enfant Promenade, SW., Washington, DC 20447, anacommissioner@acf.hhs.gov. In addition to the Tribal Consultation Session, ACF will be hosting a Tribal Training and Technical Assistance Day to provide information about ACF programs, the grants process and financial management, technical assistance available from ACF, and ACF’s Interoperability Innovation Initiative. The Tribal Training and Technical Assistance Day will take place on August 17, 2011, at the same address as the Tribal Consultation Session, listed above. ACF is encouraging tribes to send their tribal planning officers or comparable employee to attend the Tribal Training and Technical Assistance Day. Registration for both the Tribal Training and Technical Assistance Day and the Tribal Consultation Session can be made at the following Web site address: https:// www.acfconsultation.com/. The Office of Child Support Enforcement (OCSE) also will be extending an invitation to tribal leaders to engage in an additional day of consultation and dialogue concerning tribal child support issues. This consultation will take place on August 19, 2011, the day after the ACF Tribal Consultation Session. It will be held in the multipurpose room on the 7th Floor of the Aerospace Building, located at 901 D Street, SW., Washington, DC 20447. Additional information will be sent out by OCSE under separate cover. SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Friday, July 8, 2011 (76 FR 40374). The document announced that a proposed collection information had been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The document was published with an incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993–0002, 301– 796–9148. SUPPLEMENTARY INFORMATION: In FR Doc. 2011–17141, appearing on page 40374 in the Federal Register of Friday, July 8, 2011, the following correction is made: 1. On page 40374, in the first column, in the heading of the document, ‘‘[Docket No. FDA–2011–N–0237]’’ is corrected to read ‘‘[Docket No. FDA– 2008–N–0341]’’. Dated: July 11, 2011. George H. Sheldon, Acting Assistant Secretary for Children and Families. [Docket No. FDA–2011–N–0478] [FR Doc. 2011–18096 Filed 7–18–11; 8:45 am] Dated: July 14, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–18143 Filed 7–18–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice AGENCY: BILLING CODE 4184–34–P Food and Drug Administration, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–N–0341] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Applications for Food and Drug Administration Approval To Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs; Correction AGENCY: Food and Drug Administration, HHS. ACTION: PO 00000 Notice; correction. Frm 00040 Fmt 4703 Sfmt 4703 ACTION: Notice. The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee. This meeting was announced in the Federal Register of July 7, 2011 (76 FR 39882). The amendment is being made to reflect a change in the Contact Person portion of the document. There are no other changes. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993–0002, 301–796–6313, or FDA Advisory Committee Information Line, E:\FR\FM\19JYN1.SGM 19JYN1

Agencies

[Federal Register Volume 76, Number 138 (Tuesday, July 19, 2011)]
[Notices]
[Page 42713]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18143]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0341]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Applications for Food 
and Drug Administration Approval To Market a New Drug; Postmarketing 
Reports; Reporting Information About Authorized Generic Drugs; 
Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Friday, July 8, 2011 (76 FR 
40374). The document announced that a proposed collection information 
had been submitted to the Office of Management and Budget (OMB) for 
review and clearance under the Paperwork Reduction Act of 1995. The 
document was published with an incorrect docket number. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, 
Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2011-17141, appearing on page 
40374 in the Federal Register of Friday, July 8, 2011, the following 
correction is made:
    1. On page 40374, in the first column, in the heading of the 
document, ``[Docket No. FDA-2011-N-0237]'' is corrected to read 
``[Docket No. FDA-2008-N-0341]''.

    Dated: July 14, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-18143 Filed 7-18-11; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.